263 related articles for article (PubMed ID: 20926885)
1. How rapidly should remission be achieved?
Isaacs KL
Dig Dis; 2010; 28(3):548-55. PubMed ID: 20926885
[TBL] [Abstract][Full Text] [Related]
2. [New therapeutic goals in inflammatory bowel diseases].
Vuitton L; Peyrin-Biroulet L
Rev Prat; 2014 Nov; 64(9):1232-6. PubMed ID: 25638861
[TBL] [Abstract][Full Text] [Related]
3. Definition and evaluation of mucosal healing in clinical practice.
Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
[TBL] [Abstract][Full Text] [Related]
4. Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?
Flynn A; Kane S
Curr Opin Gastroenterol; 2011 Jul; 27(4):342-5. PubMed ID: 21378560
[TBL] [Abstract][Full Text] [Related]
5. Mucosal healing in inflammatory bowel disease.
Osterman MT
J Clin Gastroenterol; 2013 Mar; 47(3):212-21. PubMed ID: 23340060
[TBL] [Abstract][Full Text] [Related]
6. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
7. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
8. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease.
Orlando A; Guglielmi FW; Cottone M; Orlando E; Romano C; Sinagra E
Dig Liver Dis; 2013 Dec; 45(12):986-91. PubMed ID: 23993738
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic principles for chronic inflammatory bowel disease].
Binder V; Munkholm P
Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
[TBL] [Abstract][Full Text] [Related]
11. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
12. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
Walsh A; Palmer R; Travis S
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
[TBL] [Abstract][Full Text] [Related]
13. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
Levine DS; Fischer SH; Christie DL; Haggitt RC; Ochs HD
Am J Gastroenterol; 1992 Jan; 87(1):91-100. PubMed ID: 1728132
[TBL] [Abstract][Full Text] [Related]
15. Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors.
Papi C; Fascì-Spurio F; Rogai F; Settesoldi A; Margagnoni G; Annese V
Dig Liver Dis; 2013 Dec; 45(12):978-85. PubMed ID: 24018244
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease.
Berni Canani R; Terrin G; Borrelli O; Romano MT; Manguso F; Coruzzo A; D'Armiento F; Romeo EF; Cucchiara S
Dig Liver Dis; 2006 Jun; 38(6):381-7. PubMed ID: 16301010
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art: Immunosuppression and biologic therapy.
Sandborn WJ
Dig Dis; 2010; 28(3):536-42. PubMed ID: 20926883
[TBL] [Abstract][Full Text] [Related]
18. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
[TBL] [Abstract][Full Text] [Related]
19. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
20. The state of the art in the management of inflammatory bowel disease.
Hanauer SB; Present DH
Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
